Silo Pharma, Inc. (SILO) Stock

Healthcare · Biotechnology · Member of Other US Stocks

Silo Pharma, Inc. (SILO) closed at USD 1.20 on 2026-10-15, a change of -85.1 % over the past year, with a market capitalization of USD 2.42M.

Silo Pharma, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Silo Pharma, Inc. key figures

Previous close

USD 1.20 (2026-10-15)

1-year change

-85.1 %

Market cap

USD 2.42M

Enterprise value

USD -3.35M

P/E ratio (trailing)

-0.28

P/E ratio (forward)

-1.69

EPS (trailing)

-4.26

EPS (forward)

-0.70

PEG ratio

n/a

Price to book

0.27

Revenue growth

n/a

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

0.67

Employees

3

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Silo Pharma, Inc.

Silo Pharma, Inc. operates as a developmental stage biopharmaceutical company. The company is developing therapeutics that address underserved conditions, including post-traumatic stress disorder (PTSD), stress-induced anxiety disorders, fibromyalgia, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in formulations. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders. In addition, the company is developing SP-26, a time-release ketamine-loaded implant for fibromyalgia and chronic pain relief. In addition, the company's two preclinical programs comprise SPC-14, an intranasal compound for the treatment of Alzheimer's disease, and SPU-16, a CNS-homing peptide targeting multiple sclerosis (MS). The company's research and development programs are conducted through collaborations with Columbia University, Medspray Pharma BV, and the University of Maryland, Baltimore. The company was formerly known as Uppercut Brands, Inc. and changed its name to Silo Pharma, Inc. in September 2020. Silo Pharma, Inc. was incorporated in 2010 and is based in Sarasota, Florida.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Silo Pharma, Inc. and compare it with other stocks.